2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
NATIONAL INSTITUTES OF HEALTH NIAID (federal) is asking for bids or proposals on "2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases". Responses are due Dec 8, 3:00 p.m. EST. The notice does not list a small business set-aside. Solicitation number: HHS-NIH-NIAID-BAA2026-1.
The short version
INTRODUCTION: The National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes of the NIH, an agency within the Department of Health and Human Services (DHHS); conducts and supports research to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten the health and longevity of human lives.Through a variety of research grants and contracts, NIAID’s Division of Microbiology and Infectious Diseases (DMID) specifically supports extramural research to develop new medical interventions against infectious disease threats to include drug-resistant pathogens. NIAID/DMID intends to use this BAA to help address goals articulated in a number of strategic plans, such as in the Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan (https://aspr.hhs.gov/PHEMCE/2024-PHEMCE-SIP/Pages/default.aspx), as well as current prioritized antimicrobial resistant threats identified by national death and infection estimates as determined by the Centers for Disease Control and Prevention’s (CDC) to prevent and control antimicrobial resistance...
- Agency
- NATIONAL INSTITUTES OF HEALTH NIAID
- Level
- Federal
- Solicitation number
- HHS-NIH-NIAID-BAA2026-1
- Notice type
- solicitation
- Posted
- Nov 5, 2026
- Set-aside
- None stated
- NAICS
- 541715
Contact
Contracting Officer: Alexandra Buck, JD NIAID_DMIDOmnibusBAAQuestions@niaid.nih.gov
Summary from the public posting. Always check the official documents before you bid.